Modification of the alkaline comet assay with human mesenchymal stem cells

Robert Fuchs1, Ingeborg Stelzer, Christoph M P Drees

  • 1Institute of Pathophysiology and Immunology, Center of Molecular Medicine, Medical University of Graz, Heinrichstrasse 31A, 8010 Graz, Austria. robert.fuchs@medunigraz.at

Cell Biology International
|September 17, 2011
PubMed

Insights

Mesenchymal stem cells (MSCs) for regenerative medicine show increased DNA damage over time in culture. Optimized comet assays provide a fast screening tool to monitor and minimize MSC senescence during in vitro propagation.

Area of Science:

  • Regenerative Medicine
  • Cell Biology
  • Biotechnology

Background:

  • Mesenchymal stem cells (MSCs) are crucial for regenerative medicine.
  • In vitro propagation leads to replicative senescence in MSCs, characterized by reduced proliferation, telomere shortening, and DNA damage.
  • Monitoring MSC senescence is vital for effective therapeutic applications.

Purpose of the Study:

  • To optimize the alkaline comet assay for monitoring DNA damage in MSCs during in vitro cultivation.
  • To establish a reliable method for assessing replicative senescence in MSCs.
  • To provide a tool for minimizing senescence in MSCs used for regenerative medicine.

Main Methods:

  • Modification of comet assay slide preparation to enhance agarose gel adhesion and cell concentration.
  • Optimization focused on improving slide stability and reducing background noise.
  • Assessment of DNA integrity using the alkaline comet assay.

Main Results:

  • Optimized comet assay demonstrated increased efficiency and reproducibility.
  • Modifications minimized image capture and storage requirements.
  • Significant increase in DNA damage was observed in human MSCs with prolonged in vitro cultivation time.

Conclusions:

  • The optimized alkaline comet assay is a fast and effective tool for screening DNA damage and monitoring senescence in MSCs.
  • This method aids in efforts to minimize replicative senescence in MSCs during in vitro expansion.
  • Improved MSC quality through senescence monitoring can enhance regenerative medicine outcomes.